Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.050
-0.100 (-4.65%)
Feb 21, 2025, 4:00 PM EST - Market closed
Nkarta Employees
Nkarta had 150 employees as of December 31, 2023. The number of employees decreased by 13 or -7.98% compared to the previous year.
Employees
150
Change (1Y)
-13
Growth (1Y)
-7.98%
Revenue / Employee
n/a
Profits / Employee
-$737,393
Market Cap
144.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 150 | -13 | -7.98% |
| Dec 31, 2022 | 163 | 27 | 19.85% |
| Dec 31, 2021 | 136 | 41 | 43.16% |
| Dec 31, 2020 | 95 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
NKTX News
- 2 months ago - Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 - GlobeNewsWire
- 3 months ago - Nkarta to Participate in an Upcoming Investor Conference - GlobeNewsWire
- 3 months ago - Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - Benzinga
- 6 months ago - Nkarta to Participate in Upcoming Investor Conference - GlobeNewsWire
- 6 months ago - Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients - Seeking Alpha
- 6 months ago - Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 months ago - Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire